GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Colinz Laboratories Ltd (BOM:531210) » Definitions » Gross-Profit-to-Asset %

Colinz Laboratories (BOM:531210) Gross-Profit-to-Asset % : 36.35% (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Colinz Laboratories Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Colinz Laboratories's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₹41.29 Mil. Colinz Laboratories's average Total Assets over the quarter that ended in Mar. 2024 was ₹113.59 Mil. Therefore, Colinz Laboratories's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 36.35%.


Colinz Laboratories Gross-Profit-to-Asset % Historical Data

The historical data trend for Colinz Laboratories's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Colinz Laboratories Gross-Profit-to-Asset % Chart

Colinz Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.00 38.85 43.54 48.23 43.69

Colinz Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.22 45.07 50.82 - 36.35

Competitive Comparison of Colinz Laboratories's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Colinz Laboratories's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Colinz Laboratories's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Colinz Laboratories's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Colinz Laboratories's Gross-Profit-to-Asset % falls into.



Colinz Laboratories Gross-Profit-to-Asset % Calculation

Colinz Laboratories's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=47.163/( (102.308+113.594)/ 2 )
=47.163/107.951
=43.69 %

Colinz Laboratories's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=41.288/( (0+113.594)/ 1 )
=41.288/113.594
=36.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Colinz Laboratories Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Colinz Laboratories's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Colinz Laboratories (BOM:531210) Business Description

Traded in Other Exchanges
N/A
Address
Mulund Goregaon Link Road, A-101 Pratik Industrial Estate, Next to Fortis Hospital, Bhandup (West), Mumbai, MH, IND, 400078
Colinz Laboratories Ltd is an India based company engaged in manufacturing of pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathy, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.

Colinz Laboratories (BOM:531210) Headlines

No Headlines